Quantchabot has detected a promising Long Risk Reversal trade opportunity for ACADIA PHARMACEUTICALS (ACAD) for the 19-Jan-2024 expiration period. You can analyze the opportunity in depth over at the Quantcha Options Search Engine.
ACAD was recently trading at $20.37 and has an implied volatility of 56.80% for this period. Based on an analysis of the options available for ACAD expiring on 19-Jan-2024, there is a 37.60% likelihood that the underlying will close within the analyzed range of $20.37-$36.15 at expiration. In this scenario, the average linear return for the trade would be 73.32%.
Trending on StockTwits: StockTwits® is a financial communications platform for the financial and investing community. On their site, ACADIA PHARMACEUTICALS was recently trending, indicating that breaking news and/or market activity has significantly impacted sentiment toward the stock. This movement can be interpretted as a sign of more near-term price movement for the underlying.
Trade approach: The recent sentiment change in ACAD on StockTwits appears to be moderately positive, indicating that the stock is likely to follow in that direction for investors trading on sentiment. As a result, a bullish strategy could prove effective if the sentiment ultimately turns out to drive trading.
Upside potential: Using this bullish strategy, the trade would be profitable if ACADIA PHARMACEUTICALS closed at or above $20.30 on 19-Jan-2024. Based on our analysis, there is a 53.72% likelihood of this return.
Downside risk: As with any options trade, there is a substantial downside risk where you may lose most or all of your investment.
To analyze this trade in depth, please visit the Quantcha Options Search Engine.
Leave a Reply
You must be logged in to post a comment.